Correction
An item yesterday dealing with the stem cell agency’s affordability program incorrectly described Dana Goldman of USC as a “patient navigator.” He is a health economist.
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.